$31.2 Million is the total value of IDG-Accel China Growth Fund III Associates L.P.'s 6 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| JG | AURORA MOBILE LTDads | $10,929,000 | -48.6% | 6,544,065 | 0.0% | 35.00% | -9.5% | |
| CASI | CASI PHARMACEUTICALS INC | $9,489,000 | -23.2% | 7,973,536 | 0.0% | 30.38% | +35.2% | |
| SECO | SECOO HLDG LTDadr | $5,187,000 | -49.6% | 4,182,702 | 0.0% | 16.61% | -11.3% | |
| LAIX | LAIX INCads | $2,065,000 | -51.6% | 2,294,731 | 0.0% | 6.61% | -14.8% | |
| MOGU | MOGU INCspon ads | $2,051,000 | -41.6% | 2,114,245 | 0.0% | 6.57% | +2.9% | |
| AIH | Sell | AESTHETIC MED INTL HLDG GR Lads | $1,509,000 | -54.0% | 369,867 | -10.3% | 4.83% | -19.1% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AURORA MOBILE LTD | 8 | Q3 2021 | 45.2% |
| CASI PHARMACEUTICALS INC | 8 | Q3 2021 | 30.4% |
| SECOO HLDG LTD | 8 | Q3 2021 | 20.3% |
| LAIX INC | 8 | Q3 2021 | 10.4% |
| AESTHETIC MED INTL HLDG GR L | 8 | Q3 2021 | 9.3% |
| MOGU INC | 8 | Q3 2021 | 9.0% |
| BILIBILI INC | 3 | Q2 2020 | 60.5% |
| NIU TECHNOLOGIES | 3 | Q2 2020 | 4.6% |
View IDG-Accel China Growth Fund III Associates L.P.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-06-03 |
| 13F-HR | 2021-02-12 |
| 13F-HR | 2020-11-10 |
| 13F-HR | 2020-08-05 |
| 13F-HR | 2020-06-05 |
| 13F-HR/A | 2020-03-06 |
| 13F-HR | 2020-02-14 |
| 4 | 2018-03-23 |
View IDG-Accel China Growth Fund III Associates L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.